These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17616295)

  • 1. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives.
    Jaffe R; Strauss BH
    J Am Coll Cardiol; 2007 Jul; 50(2):119-27. PubMed ID: 17616295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is stent thrombosis the new Achilles heel of interventional cardiology? State of the Art clinical trials, causes and approaches for prevention].
    Grumann T; Diehl P; Bode C; Moser M
    Hamostaseologie; 2007 Dec; 27(5):344-50. PubMed ID: 18060244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and drug-eluting stents: an objective appraisal.
    Holmes DR; Kereiakes DJ; Laskey WK; Colombo A; Ellis SG; Henry TD; Popma JJ; Serruys PW; Kimura T; Williams DO; Windecker S; Krucoff MW
    J Am Coll Cardiol; 2007 Jul; 50(2):109-18. PubMed ID: 17616294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.
    Rodriguez AE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):561-76. PubMed ID: 19712016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stent thrombosis in the era of drug-eluting stents].
    Wöhrle J
    Herz; 2007 Aug; 32(5):411-8. PubMed ID: 17687531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late bare-metal stent thrombosis. A case report and review of the literature.
    Manjappa N; Agarwal A; Cavusoglu E
    J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
    Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
    Paradis JM; Ducrocq G; Tanguay JF
    Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.
    Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R
    Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent thrombosis.
    Steinberg DH; Satler LF
    Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.
    Jensen LO; Maeng M; Kaltoft A; Thayssen P; Hansen HH; Bottcher M; Lassen JF; Krussel LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Soerensen HT; Thuesen L
    J Am Coll Cardiol; 2007 Jul; 50(5):463-70. PubMed ID: 17662400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent thrombosis.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Dec; 56():969-79. PubMed ID: 19322976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late stent thrombosis after drug-eluting stent implantation: epidemiological, clinical and pathophysiological aspects].
    Notaristefano S; Sbarzaglia P; Cavallini C
    G Ital Cardiol (Rome); 2008 Oct; 9(10):674-83. PubMed ID: 18942555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.